CL
GSK icon

CPWM LLC’s GSK GSK Stock Holding History

CPWM LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$734K Buy
+24,943
New +$945K 0.07% 155
2022
Q2 		– Sell
-24,945
Closed -$1.36M – 385
2022
Q1 		$1.36M Hold
24,945
– – 0.1% 116
2021
Q4 		$1.19M Hold
24,945
– – 0.09% 132
2021
Q3 		$1.19M Hold
24,945
– – 0.11% 105
2021
Q2 		$1.24M Buy
24,945
+83
+0.3% +$3.99K 0.09% 106
2021
Q1 		$1.11M Buy
24,862
+60
+0.2% +$2.72K 0.1% 130
2020
Q4 		$1.14M Sell
24,802
-157
-0.6% -$7.21K 0.1% 124
2020
Q3 		$1.17M Sell
24,959
-243
-1% -$12.2K 0.12% 110
2020
Q2 		$1.28M Buy
25,202
+127
+0.5% +$6.52K 0.15% 98
2020
Q1 		$1.19M Buy
25,075
+199
+0.8% +$10.6K 0.17% 94
2019
Q4 		$1.46M Hold
24,876
– – 0.18% 87
2019
Q3 		$1.33M Hold
24,876
– – 0.17% 94
2019
Q2 		$1.24M Sell
24,876
-1,359
-5% -$68.2K 0.17% 86
2019
Q1 		$1.37M Buy
26,235
+66
+0.3% +$3.3K 0.2% 83
2018
Q4 		$1.25M Sell
26,169
-1,083
-4% -$53.3K 0.21% 81
2018
Q3 		$1.37M Sell
27,252
-1,509
-5% -$76.7K 0.19% 87
2018
Q2 		$1.45M Sell
28,761
-279
-1% -$14.1K 0.22% 87
2018
Q1 		$1.42M Buy
+29,040
New +$1.35M 0.22% 89
2014
Q4 		– Sell
-5,439
Closed -$313K – 168
2014
Q3 		$313K Buy
5,439
+504
+10% +$30.9K 0.11% 89
2014
Q2 		$330K Buy
4,935
+888
+22% +$60.1K 0.12% 80
2014
Q1 		$270K Buy
4,047
+646
+19% +$43.7K 0.1% 94
2013
Q4 		$227K Hold
3,401
– – 0.09% 102
2013
Q3 		$212K Hold
3,401
– – 0.09% 101
2013
Q2 		$212K Buy
+3,401
New +$216K 0.09% 101

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

CPWM LLC's GSK Position: Q3 2022 in Review

CPWM LLC opened a new position in GSK (GSK) in Q3 2022: 24,943 shares worth $734K. The stake represents 0.07% of the portfolio and ranks #155 among its holdings. This is a return to the name: CPWM LLC previously reported a position in GSK as recently as Q1 2022.

CPWM LLC first reported a position in GSK in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.46M in Q4 2019. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • CPWM LLC held 24,943 shares of GSK worth $734K as of Q3 2022.
  • GSK was a new CPWM LLC position in Q3 2022.
  • GSK made up 0.07% of CPWM LLC's portfolio in Q3 2022, its #155 holding.
  • CPWM LLC first reported a position in GSK in Q2 2013 and has held it in 24 quarters since.
  • CPWM LLC's GSK position peaked at $1.46M in Q4 2019.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on CPWM LLC's 13F filing for Q3 2022, filed 14 Nov 2022.